Emergent Biosolutions Financials

Values in thousands	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Revenue	$234,300	$156,100	$148,700	$231,100
Gross Profit	137,200	67,600	46,600	129,100
EBITDA	-156,300	48,500	-12,500	96,600
EBIT		24,400	-36,000	72,800
Net Income	-180,200	6,800	-54,600	51,200
Net Change In Cash	234,300	156,100	148,700	231,100
Free Cash Flow	54,000	-36,200	73,800	-5,700
Cash	139,700	160,300	205,400	245,500
Basic Shares	51,600	56,500	52,400	56,500

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$742,900	$1,043,599	$1,049,300	$1,117,500
Gross Profit	350,600	375,400	360,000	473,000
EBITDA	240,400	53,400	-47,000	15,700
EBIT	142,100	-52,200	-168,100	-109,300
Net Income	52,600	-190,600	-760,500	-211,600
Net Change In Cash	742,900	1,043,599	1,049,300	1,117,500
Cost of Revenue				65,800
Free Cash Flow	156,800	35,800	-257,900	-149,900
Cash	205,400	99,500	111,700	642,600
Basic Shares	56,700	53,000	51,200	50,100